Home - Products - Others - Other Targets - 1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE)

1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE)

CAS No. 3312-04-7

1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE)( 4-oxo-1,4-dihydroquinoline-2-carboxylic acid )

Catalog No. M22260 CAS No. 3312-04-7

1,1'-(4-Chlorobutylidene)bis(4-fluorobenzene) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 50 In Stock
10MG 71 In Stock
25MG 128 In Stock
50MG 182 In Stock
100MG 273 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1,1'-(4-CHLOROBUTYLIDENE)BIS(4-FLUOROBENZENE)
  • Note
    Research use only, not for human use.
  • Brief Description
    1,1'-(4-Chlorobutylidene)bis(4-fluorobenzene) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.
  • Description
    1,1'-(4-Chlorobutylidene)bis(4-fluorobenzene) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-oxo-1,4-dihydroquinoline-2-carboxylic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3312-04-7
  • Formula Weight
    280.74
  • Molecular Formula
    C16H15ClF2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-(2-{bis[2-(2,2-dic...

    N-(2-{bis[2-(2,2-dichloroacetamido)ethyl]amino}ethyl)-2,2-dichloroacetamide hydrochloride is a chemical compound.

  • HJC0197

    HJC0197 selectively blocks cAMP-induced Epac activation. HJC0197 is an effective exchange protein. Which straightly activated by cAMP (Epac) antagonist (IC50=5.9 μM for Epac2).

  • Norswertianin

    Norswertianin, a xanthone compound, serves as a powerful anti-glioma compound. Norswertianin induces GBM cells differentiation through oxidative stress and Akt/mTOR dependent autophagy.